Reproducibility of qualitative assessments of temporal lobe atrophy in MRI studies

S Sarria-Estrada1, C Acevedo1, R Mitjana1

  • 1Unitat Ressonància Magnètica (I.D.I.), Servei de Radiología, Hospital Universitari Vall d'Hebron, Barcelona, España.

Radiologia
|June 28, 2014
PubMed
Abstract

Insights

The Scheltens visual rating scale reliably measures medial temporal lobe atrophy in Alzheimer's disease and mild cognitive decline. This scale demonstrates strong reproducibility among observers, supporting its clinical use.

Area of Science:

  • Neurology
  • Radiology
  • Medical Imaging

Background:

  • Medial temporal lobe atrophy is a key indicator in diagnosing Alzheimer's disease (AD) and mild cognitive decline (MCD).
  • Accurate and reproducible visual rating scales are crucial for consistent clinical assessment and research.

Purpose of the Study:

  • To assess the reproducibility of the Scheltens visual rating scale for medial temporal lobe atrophy.
  • To validate the scale's reliability in differentiating between cognitive decline and healthy controls.

Main Methods:

  • Coronal T1-weighted MRI sequences were acquired on a 1.5 Tesla scanner.
  • Twenty-five patients with AD/MCD and 25 controls were analyzed by five trained neuroradiologists.
  • Interrater and intrarater agreement were evaluated using the interclass correlation coefficient.

Main Results:

  • The Scheltens scale effectively differentiated between patients with cognitive decline (scores 2-4) and controls (scores 0-1).
  • Excellent interrater agreement (ICC > 0.82) and strong intrarater agreement (ICC 0.82-0.87) were observed.
  • High concordance suggests reliable application of the scale across different readers and over time.

Conclusions:

  • The Scheltens visual rating scale exhibits high reproducibility among observers.
  • This validated reproducibility supports the scale's utility in routine clinical practice for assessing medial temporal lobe atrophy.

Related Concept Videos